BICYCLE THERAPEUTICS PLC (BCYC) has 138 open-market insider trades by 22 insiders since 2019. Over the last six months insiders net sold $112K. The most active filer is Kevin Lee, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Baker Bros. Advisors (GP) LLC via Felix Baker | Dir10% Owner | — | 1 | $42.4M | 2024-12-16 |
| Pierre Legault | Dir | — | 5 | $10.0M | 2025-01-02 |
| Kevin Lee | CEO | — | 29 | $9.8M | 2026-10-05 |
| Carolyn Ng | Dir | — | 1 | $8.0M | 2019-05-28 |
| Kate Bingham | Dir | — | 2 | $6.9M | 2021-07-14 |
| Glaxosmithkline PLC | 10% Owner | — | 2 | $5.6M | 2020-07-15 |
| Deborah Harland | Dir | — | 1 | $5.4M | 2019-05-28 |
| Aquila Investments IV | 10% Owner | — | 1 | $5.1M | 2019-05-28 |
| Cambridge Innovation Capital (Jersey) Ltd | 10% Owner | — | 1 | $4.4M | 2019-05-29 |
| Michael Anstey | Dir | — | 1 | $4.4M | 2019-05-28 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Jennifer Scott Perry | COO | Sell | $107 | 2026-10-05 |
| Kevin Lee | CEO | Sell | $27K | 2026-10-02 |
| Michael Skynner | CSO | Sell | $9K | 2026-10-02 |
| Travis Alvin Thompson | CFO | Sell | $3K | 2026-10-02 |
| Jennifer Scott Perry | COO | Sell | $5K | 2026-10-02 |
| Michael Charles Ferguson Hannay | — | Sell | $6K | 2026-10-02 |
Companies that share insiders with BCYC, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Robert Charles Swanton | Director | Sell | $12K | 2026-10-02 |
| Kevin Lee | CEO | Sell | $33K | 2026-07-02 |
| Michael Charles Ferguson Hannay | — | Sell | $8K | 2026-07-02 |
| Jennifer Scott Perry | COO | Sell | $6K | 2026-07-02 |
| Michael Skynner | CSO | Sell | $10K | 2026-07-02 |
| Travis Alvin Thompson | CFO | Sell | $4K | 2026-07-02 |
| Travis Alvin Thompson | CFO | Sell | $4K | 2026-04-02 |
| Michael Skynner | CSO | Sell | $12K | 2026-04-02 |
| Michael Charles Ferguson Hannay | — | Sell | $9K | 2026-04-02 |